GSS — Genetic Signatures Cashflow Statement
0.000.00%
Last trade - 00:00- AU$93.13m
- AU$53.35m
- AU$14.27m
- 68
- 30
- 35
- 43
Annual cashflow statement for Genetic Signatures, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.129 | 0.326 | 0.126 | 0.565 | 0.483 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -9.49 | 4.2 | 9.81 | -12.5 | -10.1 |
| Capital Expenditures | -2.35 | -4.98 | -2.99 | -8.09 | -4.79 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -2.35 | -4.98 | -2.99 | -8.09 | -4.79 |
| Financing Cash Flow Items | -1.89 | -0.012 | -0.009 | -0.001 | -2.53 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 36.7 | -0.19 | -0.101 | -0.023 | 34.8 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 24.9 | -1.05 | 6.78 | -20.5 | 19.9 |